CommentaryAttenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
Keywords
Allogeneic stem cell transplantation
COVID-19
Graft-versus-host disease
Immunocompromised
JAK inhibitor
Cited by (0)
© 2020 Published by Elsevier Inc.